TriSalus Life Sciences (TLSI) Competitors $4.05 +0.45 (+12.50%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TLSI vs. TMCI, CLPT, TCMD, NNOX, DCTH, ZIMV, NPCE, RCEL, CVRX, and SMTIShould you be buying TriSalus Life Sciences stock or one of its competitors? The main competitors of TriSalus Life Sciences include Treace Medical Concepts (TMCI), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Nano-X Imaging (NNOX), Delcath Systems (DCTH), ZimVie (ZIMV), NeuroPace (NPCE), AVITA Medical (RCEL), CVRx (CVRX), and Sanara MedTech (SMTI). These companies are all part of the "medical equipment" industry. TriSalus Life Sciences vs. Treace Medical Concepts ClearPoint Neuro Tactile Systems Technology Nano-X Imaging Delcath Systems ZimVie NeuroPace AVITA Medical CVRx Sanara MedTech Treace Medical Concepts (NASDAQ:TMCI) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, community ranking, risk, profitability, media sentiment, valuation and dividends. Is TMCI or TLSI more profitable? Treace Medical Concepts has a net margin of -30.33% compared to TriSalus Life Sciences' net margin of -206.24%. TriSalus Life Sciences' return on equity of 0.00% beat Treace Medical Concepts' return on equity.Company Net Margins Return on Equity Return on Assets Treace Medical Concepts-30.33% -51.12% -26.36% TriSalus Life Sciences -206.24%N/A -236.83% Does the media prefer TMCI or TLSI? In the previous week, Treace Medical Concepts had 1 more articles in the media than TriSalus Life Sciences. MarketBeat recorded 10 mentions for Treace Medical Concepts and 9 mentions for TriSalus Life Sciences. TriSalus Life Sciences' average media sentiment score of 0.84 beat Treace Medical Concepts' score of 0.25 indicating that TriSalus Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TriSalus Life Sciences 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate TMCI or TLSI? Treace Medical Concepts presently has a consensus price target of $7.88, suggesting a potential upside of 13.22%. TriSalus Life Sciences has a consensus price target of $11.79, suggesting a potential upside of 191.01%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, analysts plainly believe TriSalus Life Sciences is more favorable than Treace Medical Concepts.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Treace Medical Concepts 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00TriSalus Life Sciences 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 3.22 Does the MarketBeat Community prefer TMCI or TLSI? Treace Medical Concepts received 13 more outperform votes than TriSalus Life Sciences when rated by MarketBeat users. However, 100.00% of users gave TriSalus Life Sciences an outperform vote while only 45.28% of users gave Treace Medical Concepts an outperform vote. CompanyUnderperformOutperformTreace Medical ConceptsOutperform Votes2445.28% Underperform Votes2954.72% TriSalus Life SciencesOutperform Votes11100.00% Underperform VotesNo Votes Do insiders and institutionals hold more shares of TMCI or TLSI? 84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 2.6% of TriSalus Life Sciences shares are owned by institutional investors. 24.4% of Treace Medical Concepts shares are owned by insiders. Comparatively, 32.8% of TriSalus Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has higher valuation and earnings, TMCI or TLSI? Treace Medical Concepts has higher revenue and earnings than TriSalus Life Sciences. Treace Medical Concepts is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTreace Medical Concepts$202.86M2.14-$49.53M-$0.99-7.03TriSalus Life Sciences$18.51M6.67-$59.04M-$2.49-1.63 Which has more risk & volatility, TMCI or TLSI? Treace Medical Concepts has a beta of 0.66, meaning that its stock price is 34% less volatile than the S&P 500. Comparatively, TriSalus Life Sciences has a beta of 0.56, meaning that its stock price is 44% less volatile than the S&P 500. SummaryTriSalus Life Sciences beats Treace Medical Concepts on 10 of the 19 factors compared between the two stocks. Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Get TriSalus Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TLSI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLSI vs. The Competition Export to ExcelMetricTriSalus Life SciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$123.48M$4.34B$5.14B$9.08BDividend YieldN/A44.57%5.09%4.23%P/E Ratio-1.6325.3789.8217.18Price / Sales6.6745.921,116.21116.95Price / CashN/A43.4542.8937.86Price / Book-4.137.094.784.78Net Income-$59.04M$13.64M$120.23M$225.60M7 Day Performance3.58%-2.93%-1.92%-1.23%1 Month Performance-8.58%0.28%11.49%3.36%1 Year Performance-49.69%40.76%30.57%16.60% TriSalus Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLSITriSalus Life Sciences4.021 of 5 stars$4.05+12.5%$11.79+191.0%-50.5%$123.48M$18.51M-1.63106Analyst ForecastInsider TradeNews CoveragePositive NewsGap UpHigh Trading VolumeTMCITreace Medical Concepts1.7006 of 5 stars$7.59+1.2%$7.40-2.5%-36.6%$472.86M$187.12M-7.58250Analyst ForecastNews CoverageCLPTClearPoint Neuro0.45 of 5 stars$16.18+5.6%$11.33-30.0%+142.2%$446.33M$30.43M-22.21110Positive NewsTCMDTactile Systems Technology3.5784 of 5 stars$17.89-0.2%$23.00+28.6%+23.9%$429.36M$274.42M27.57980Analyst UpgradeNNOXNano-X Imaging2.3594 of 5 stars$7.36+6.8%$12.00+63.0%+2.9%$425.25M$10.68M-8.79190Positive NewsDCTHDelcath Systems2.8196 of 5 stars$12.22+0.9%$21.50+75.9%+212.8%$390.72M$22.64M-9.6776Gap DownHigh Trading VolumeZIMVZimVie2.3679 of 5 stars$13.73flat$18.33+33.5%-20.6%$378.95M$457.43M-1.052,600NPCENeuroPace3.7644 of 5 stars$11.47+4.0%$14.60+27.3%+24.4%$342.36M$76.45M-11.03170Analyst ForecastPositive NewsRCELAVITA Medical1.6504 of 5 stars$12.53+2.6%$16.50+31.7%-5.3%$328.54M$50.14M-5.48130News CoveragePositive NewsCVRXCVRx3.7816 of 5 stars$13.38+4.3%$16.67+24.6%-49.2%$324.65M$47.26M-4.75200Positive NewsSMTISanara MedTech1.9969 of 5 stars$33.83-2.4%$44.00+30.1%-14.5%$295.67M$64.99M-35.0060 Related Companies and Tools Related Companies Treace Medical Concepts Competitors ClearPoint Neuro Competitors Tactile Systems Technology Competitors Nano-X Imaging Competitors Delcath Systems Competitors ZimVie Competitors NeuroPace Competitors AVITA Medical Competitors CVRx Competitors Sanara MedTech Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TLSI) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TriSalus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLSI Stock Alerts